综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

SHANGHAI: Huayi Group plans to invest about 100 million yuan in a pilot project to manufacture a medicine for diabetics that it developed through its own research.

Related readings:  Stricter quality checks on 170,000 medicines

"The board has approved the project which will be launched in the third quarter of this year," said Zhang Peizhang, chairman of Shanghai Huayi Group.

A plant to make the medicine will be located in Shanghai's Nanhui International Medical Science Park and will cover an area of about 5 hectares when completed.

The new drug, named "Yishengtai", is "China's first effort in developing drugs for diabetics by using its own intellectual property rights", said Wu Dengxi, director of the Shanghai Huayi Bio-Lab Co Ltd.

"It will be put into production in two years if things go on smoothly," said Zhang.

The company has applied to the State for patent, he said.

Clinical experiments on the drug began in 2004 after it was registered with the State Drug and Food Administration.

"Much valuable data was collected from these experiments, proving that the new drug is helpful to those who are suffering from type-II diabetes," said Li Guangwei, a professor at the Sino-Japan Friendship Hospital, who has been involved in the experiments.

1

2

(For more biz stories, please visit Industry Updates)